Ticlopidine
Brand names,
Ticlopidine
Analogs
Ticlopidine
Brand Names Mixture
Ticlopidine
Chemical_Formula
C14H14ClNS
Ticlopidine
RX_link
http://www.rxlist.com/cgi/generic/ticlop.htm
Ticlopidine
fda sheet
Ticlopidine
msds (material safety sheet)
Ticlopidine
Synthesis Reference
No information avaliable
Ticlopidine
Molecular Weight
263.786 g/mol
Ticlopidine
Melting Point
No information avaliable
Ticlopidine
H2O Solubility
Freely soluble
Ticlopidine
State
Solid
Ticlopidine
LogP
3.46
Ticlopidine
Dosage Forms
Tablets (for oral administration, containing 250 mg of ticlopidine hydrochloride)
Ticlopidine
Indication
Used to reduce the risk of thrombotic stroke (fatal or nonfatal) in patients who have experienced stroke precursors, and in patients who have had a completed thrombotic stroke.
Ticlopidine
Pharmacology
Ticlopidine is a platelet aggregation inhibitor structurally and pharmacologically similar to clopidogrel. When taken orally, ticlopidine causes a time- and dose-dependent inhibition of both platelet aggregation and release of platelet granule constituents, as well as a prolongation of bleeding time. The intact drug has no significant in vitro activity at the concentrations attained in vivo; and, although analysis of urine and plasma indicates at least 20 metabolites, no metabolite which accounts for the activity of ticlopidine has been isolated.
Ticlopidine
Absorption
Absorption is greater than 80%. Food increases absorption.
Ticlopidine
side effects and Toxicity
Single oral doses of ticlopidine at 1600 mg/kg and 500 mg/kg were lethal to rats and mice, respectively. Symptoms of acute toxicity were GI hemorrhage, convulsions, hypothermia, dyspnea, loss of equilibrium and abnormal gait.
Ticlopidine
Patient Information
Ticlopidine
Organisms Affected
Humans and other mammals